Category: Joint ventures/collaborations
-
Jet Fuel from Carbon Waste Powers Virgin Atlantic Flight
A Virgin Atlantic flight arriving earlier today from Orlando, Florida to London’s Gatwick airport is the first to use a biofuel made from fermented carbon-rich industrial waste gases.
-
Human Antibodies Devised for Snakebite Treatment
An academic-industry team in Europe and Central America assembled a group of human antibodies that protects lab mice against venomous toxins from a dangerous African snake.
-
Mayo Clinic, Helix Partner on Genomic Analysis
Mayo Clinic and the company Helix Opco are providing a genomic analysis service for Mayo Clinic patients seeking more detailed insights into their genetic make-up and health outlook.
-
Novartis, NGO Partner on Generic Antibiotics
Drug maker Novartis and a not-for-profit organization delivering antibiotics for low- and middle-income countries are collaborating on production of generic antibiotics for children.
-
Synthetic Antibody Neutralizing Gluten in Development
An academic-business team is developing a synthetic antibody to prevent gluten found in some grains from affecting the intestines of people with celiac disease, an intolerance of gluten.
-
Algorithms Advance Assistive Control for Spinal Cord Injury
A system to control movements of an assistive sleeve is shown in lab tests to enable a person with no use of his arms and legs due to spinal cord injury to accurately grasp and release objects.
-
Spin-Off Company Developing New Antibiotics
A start-up enterprise in the U.K. is commercializing research from a university lab that discovered a new class of antibiotics promising to treat drug-resistant bacterial infections.
-
Exosuit Designed for Personalized Walking Help
A wearable robotic exoskeleton designed into textiles to provide personalized assistance is shown in lab and field tests to reduce the amount effort needed to walk long distances.
-
Gilead Gains Genome-Editing Hepatitis B Therapy
Biopharmaceutical company Gilead Sciences is acquiring a genome-editing technology for treating hepatitis-B, a viral disease affecting the liver.
-
Personalized Breast Cancer Trial Advances 7 Drugs
A clinical trial with a design that allows for changes in its processes to meet the needs of individual patients says its results helped advance 7 new drugs for breast cancer into review by FDA.